Industry
Drug Manufacturers - Specialty & Generic
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Loading...
Open
9.43
Mkt cap
3.5B
Volume
2.7M
High
9.50
P/E Ratio
-19.62
52-wk high
11.46
Low
9.19
Div yield
N/A
52-wk low
3.96
Portfolio Pulse from Benzinga Newsdesk
November 01, 2024 | 7:45 pm
Portfolio Pulse from Avi Kapoor
November 01, 2024 | 4:13 pm
Portfolio Pulse from Benzinga Newsdesk
November 01, 2024 | 3:28 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 1:58 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 8:35 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 8:10 pm
Portfolio Pulse from Benzinga Newsdesk
October 28, 2024 | 6:58 am
Portfolio Pulse from Anthony Noto
October 26, 2024 | 6:31 pm
Portfolio Pulse from Anthony Noto
October 21, 2024 | 6:46 pm
Portfolio Pulse from Benzinga Newsdesk
October 21, 2024 | 5:39 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.